Key facts
- This page summarizes Mark D. Smith's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2024, 16:10.
Mark D. Smith - 15 Aug 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)
- Reporting relationship
- Director
- Issuer ticker
- TDOC
- Reported as of
- 15 Aug 2024
- Net transaction value
- +$28,312
- SEC form
- 4
- Accepted by SEC
- 19 Aug 2024, 16:10:41 UTC
- Prior SEC filing
- 06 Aug 2024
- Next SEC filing
- 23 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adam C. Vandervoort, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark D. Smith filed Form 4 for Teladoc Health, Inc. (TDOC) on 19 Aug 2024.
Change
- Previous filing in this sequence was filed on 06 Aug 2024.
- Current net transaction value: +$28,312.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TDOC
transaction
Common Stock
Purchase
- Transaction value
- $28,312
- Shares
- +4,000
- Change %
- +92%
- Price
- $7.08
- Shares after
- 8,355
- Date
- 15 Aug 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.